US Stock MarketDetailed Quotes
NXL Nexalin Technology
- 0.9000
- +0.1190+15.24%
Close Oct 14 16:00 ET
- 0.8988
- -0.0012-0.13%
Post 18:23 ET
9.53MMarket Cap-1250P/E (TTM)
0.9699High0.7667Low217.58KVolume0.8000Open0.7810Pre Close191.88KTurnover2.68%Turnover RatioLossP/E (Static)10.59MShares4.050052wk High7.03P/B7.31MFloat Cap0.252852wk Low--Dividend TTM8.12MShs Float4.0500Historical High--Div YieldTTM26.02%Amplitude0.2528Historical Low0.8810Avg Price1Lot Size
About Nexalin Technology Company
Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices helps people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.
Company Profile
SymbolNXL
Company NameNexalin Technology
Listing DateSep 16, 2022
Issue Price4.14
Founded2010
CEOMr. Mark White
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address1776 Yorktown,Suite 550
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77056
Phone1-832-260-0222
Websitehttp://www.nexalin.com
Company Executives
- Name
- Position
- Salary
- Mark White
- President, Chief Executive Officer, Chief Financial Officer and Director
- 679.82K
- Dr. David Owens, M.D.
- Chief Medical Officer and Director
- 154.48K
- Carolyn Shelton
- Senior Vice President, Quality, Regulatory and Clinical Affairs
- --
- Leslie Bernhard
- Chairman of the Board
- --
- Alan Kazden
- Independent Director
- --
- Dr. Benjamin V. Hue, M.D.
- Independent Director
- --
- Marilyn Elson
- Controller
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
